New Delhi, April 26: India’s drug regulator has granted emergency use authorisation for Biological E’s COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech’s Covaxin for children in the age group of six to 12 years, Union Health Minister Mansukh Mandaviya said on Tuesday. The Drugs Controller General of India (DCGI) […]Continue Reading
New Delhi, March 17: Over 3 lakh children between 12 and 14 years have received their first shot of Covid vaccine taking the total doses administered in the country to over 180.80 crore, according to Union Health Ministry data. The vaccination against COVID-19 in the age group of 12-14 years started on Wednesday with Biological […]Continue Reading
New Delhi, March 9 : Hyderabad-based pharmaceutical company Biological E has applied for Emergency Use Authorisation (EUA) for its COVID-19 vaccine Corbevax for the 5-12 year age group, official sources said on Wednesday. The data has been submitted by the company to the Subject Expert Committee for beneficiaries between 5-12 years of age, the sources […]Continue Reading
